Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETFThe Motley Fool • 5h
Which Healthcare ETF Is the Better Buy: State Street's Pharma XPH or Simplify's Mission-Driven PINK?The Motley Fool • Monday
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?Zacks Investment Research • 10/21/26
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting PharmaThe Motley Fool • 10/10/26
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?Zacks Investment Research • 10/08/26
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPHThe Motley Fool • 09/10/26
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?The Motley Fool • 09/10/26
Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPHThe Motley Fool • 08/12/26
Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH?The Motley Fool • 07/08/26
US FDA to monitor clinical trial data in real time in pilot program aimed at speeding approvalsReuters • 04/28/26